Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation - FV Assumptions (Details)

v3.23.2
Stock Based Compensation - FV Assumptions (Details) - $ / shares
3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Weighted average assumptions          
Number of shares, Granted       796,802  
Exercise price (in dollars per share)       $ 23.50  
2010 Plan          
Weighted average assumptions          
Weighted-average grant-date fair value (in dollars per share)       13.46 $ 12.21
Stock Option Inducement Award, Exercise price of $18.66 per share          
Weighted average assumptions          
Number of shares, Granted 0   0   0
Exercise price (in dollars per share)   $ 18.66   $ 18.66  
Weighted-average grant-date fair value (in dollars per share)   11.91      
Stock Option Inducement Award, Exercise price of $30.00 per share          
Weighted average assumptions          
Number of shares, Granted 0   0   0
Exercise price (in dollars per share)   30.00      
Weighted-average grant-date fair value (in dollars per share)   $ 14.68      
Stock Options | 2010 Plan          
Weighted average assumptions          
Dividend yield 0.00%   0.00% 0.00% 0.00%
Expected volatility 70.00%   69.00% 70.00% 70.00%
Risk-free interest rate 3.60%   2.90% 3.60% 2.17%
Expected term 5 years 9 months 14 days   5 years 7 months 9 days 5 years 9 months 14 days 5 years 7 months 24 days
Stock Options | Stock Option Inducement Award, Exercise price of $18.66 per share          
Weighted average assumptions          
Dividend yield       0.00%  
Expected volatility       69.00%  
Risk-free interest rate       3.92%  
Expected term       5 years 9 months 14 days  
Stock Options | Stock Option Inducement Award, Exercise price of $30.00 per share          
Weighted average assumptions          
Dividend yield       0.00%  
Expected volatility       91.00%  
Risk-free interest rate       3.86%  
Expected term       8 years 3 days